Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,379,785

« Back to Dashboard

Summary for Patent: 4,379,785

Title: Heterocyclic substituted sulfonyl ureas, and their use
Abstract:What are disclosed are sulfonyl ureas of the formula ##STR1## in which R.sup.1, X and Y are as defined in the specification, and their physiologically acceptable salts, pharmaceutical formulations on the basis of these compounds, and their use in the treatment of diabetes.
Inventor(s): Weyer; Rudi (Kelkheim, DE), Hitzel; Volker (Hofheim am Taunus, DE), Geisen; Karl (Frankfurt am Main, DE), Regitz; Gunter (Bad Soden am Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:06/217,524
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,379,785

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2951135Dec 19, 1979

International Patent Family for Patent: 4,379,785

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany3067390► Subscribe
Spain498227► Subscribe
Spain8202799► Subscribe
Spain8202798► Subscribe
Spain498226► Subscribe
Spain498225► Subscribe
Spain8202541► Subscribe
Spain498224► Subscribe
European Patent Office0031058► SubscribeSPC/GB97/012United Kingdom► Subscribe
European Patent Office0031058► Subscribe98C0008Belgium► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus